Stock GMTX GEMI THER
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News GEMI THER

Equities

GMTX

US36870G1058

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Arix portfolio firm Disc Medicine seals Gemini Therapeutics merger
AN
DISC MEDICINE, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Amendment or Waiver to Code of Ethics, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Gemini Therapeutics, Inc.(NasdaqGM:GMTX) dropped from NASDAQ Composite Index
CI
Disc Medicine, Inc. completed the acquisition of Gemini Therapeutics, Inc. for approximately $200 million in a reverse merger transaction.
CI
GEMINI THERAPEUTICS, INC. /DE : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)
AQ
Gemini Therapeutics Shares Rise After Disc Medicine Gets FDA Designation
DJ
GEMINI THERAPEUTICS, INC. /DE : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Gemini Therapeutics' Disc Medicine Secures FDA's Orphan Drug Status for Erythropoietic Protoporphyria Treatment
MT
Disc Medicine Announces Several Presentations Across Hematology Portfolio at the 64th American Society of Hematology Annual Meeting
AQ
GEMINI THERAPEUTICS, INC. /DE : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
GEMINI THERAPEUTICS, INC. /DE : Change in Directors or Principal Officers (form 8-K)
AQ
GEMINI THERAPEUTICS, INC. /DE Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Gemini Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
GEMINI THERAPEUTICS, INC. /DE : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCKT, RCOR, EVOP, GMTX
PR
Gemini Therapeutics, Inc.(NasdaqGM:GMTX) dropped from S&P Global BMI Index
CI
GEMINI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Gemini Therapeutics, Inc. - GMTX
BU
SHAREHOLDER ALERT: Weiss Law Investigates Gemini Therapeutics, Inc.
PR
GEMINI THERAPEUTICS, INC. /DE Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Gemini Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GMTX Stock
  4. News GEMI THER